Averaging up to 20% of weight loss, adults taking Tirzepatide had at least 25 fewer breathing interruptions each hour as they ...
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
The US Food and Drug Administration (FDA) has announced a final rule expanding the approval pathway for nonprescription drug ...
The US Food and Drug Administration (FDA)’s recently issued final rule establishing application, labeling, and postmarketing reporting ...
A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...
MANILA—The Food and Drug Administration (FDA) is eyeing to expand the scope of discounted medicines and medical devices not only for senior citizens, but also for persons with disabilities (PWDs). In ...
Leqembi is the only FDA-approved anti-amyloid therapy that potentially could offer the convenience of a subcutaneous injection with at-home administration option. The Prescription Drug User Fee ...
Popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated ...
Findings from the latest New Zealand Drugs Trends Survey (NZDTS) reveal progress with the uptake of the Medicinal Cannabis ...
Having prescription drug coverage will help you avoid paying ... and medical journals and associations. We only use quality, credible sources to ensure content accuracy and integrity.
If successful, the drug developed by Vertex ... saying that only a fraction of patients who receive a short-term prescription for opioids after simple surgeries get addicted.